first generation glp-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease A Brief History of GLP-1

The key difference is concentration

As a result of their association with DM, Chen et al

Furthermore, oxidative DNA damage, characterized by the formation of 8-oxoguanine, has been implicated in renal tubular epithelial cell injury

For example: A standard GLP-1 weight-loss dose often increases over time A micro-dose stays very low and often remains there A micro-dose is typically used to: Reduce inflammation Improve metabolic function Calm the nervous system Support gut function Reduce pain or swelling Avoid the common side effects seen with full therapeutic doses More importantly, women with Lipedema usually respond better to low, slow, and gentle dosing

The metabolic process involves the activity of upstream macromolecules such as DNA and proteins